|
Whats
New Updates!
We have lots of news to share.
Click on any of the links below for the full story.
GRF PLEDGES $500,000 TO MORRIS ANIMAL FOUNDATION FOR CANINE
CANCER RESEARCH
Denver/May 1, 2007 –
The Golden Retriever Foundation (GRF) has responded to the
launch of Morris Animal Foundation’s Canine Cancer Campaign with
a pledge of $500,000 over a five-year period. The organization
becomes the first breed foundation or club to pledge a major
gift to this project.
“Cancer is the leading cause of
death among Goldens, as it is among many breeds,” said David
Kinghorn, GRF president. “We hope that other breed groups will
follow our lead and support this important endeavor.”
The Canine Cancer Campaign is an
unprecedented $30 million effort to cure canine cancer within a
dog’s lifetime – the next 10 to 20 years. With this gift, the
Golden Retriever Foundation will become the first MAF Hero
(those who give $500,000 to $999,999 to the campaign.)
“We are very excited to become
involved in this cancer campaign on the ground level,” Kinghorn
said. “Lymphoma and hemangiosarcoma are two of the cancers that
most affect Golden Retrievers. We believe the research funded
through this campaign will lead to treatments for these cancers
and will help to improve the health of Goldens.”
“The Golden Retriever Foundation has
been an excellent partner in Morris Animal Foundation’s mission
to improve canine health,” said Dr. Patricia Olson,
president/CEO of Morris Animal Foundation. “As the proud parent
of a Golden named Socrates, I truly appreciate this gift. The
MAF Canine Cancer Campaign will make great strides in
prevention, treatment and hopefully cures for cancer, which
affects half of all dogs over the age of 2.”
CHANGE TO THE APRIL FUND GRANT GUIDELINES
After careful analysis of the requests for April Fund grants
over the past five years and GRF's ability to generate donations
to that fund, the directors have changed the policy governing April
Fund grants.
As
of July 1, 2006, there will be a $5,000 cap on
the amount which any one rescue group may receive annually from
the April Fund.
This cap may be waived in
emergency situations.
This figure is set comfortably above
the average annual request to accommodate groups that accept a
higher number of needy dogs. It allows for expanded use of the
fund by more groups and ensures an equitable distribution of the
available funds among all groups. It is consistent with GRF’s
ability to raise the necessary money on a continuing basis. The
unexpected will always occur and this policy takes into account
natural disasters, puppy mill closings, and similar emergencies.
The GRF is committed to remaining flexible and responsive to
the needs of rescue, and the Directors feel that this policy
change will ensure that ability in the future.
For complete guidelines for April
Fund grants, click here.
NEW ADDRESS FOR DONATIONS
The Golden Retriever Foundation has a new address for donations
only. Now
your checks will be deposited immediately by the bank, giving
you faster
service, better accounting, and more security. So, the next
time you make a
gift to the GRF, please mail it to the following address:
Golden Retriever Foundation
PO Box 3462
Omaha, NE 68103
All other correspondence, including grant requests, should
continue to be
sent to the official mailing address at PO Box 628, Elkhorn, NE
68022.
GRF AWARDS THREE
GRANTS TO MORRIS ANIMAL FOUNDATION
|
 |
The Golden
Retriever Foundation (GRF) has entered into its first
collaborative research efforts with the Morris Animal
Foundation (MAF) of Baltimore, MD. The two Foundations will
jointly sponsor research in two areas of concern to Golden
Retriever owners – canine lymphoma and hereditary
cataracts.
Two studies,
to which the GRF is contributing $10,000 each, will be
funded from money donated to the Zeke Memorial Cancer
Research Fund. The third study will be funded by $10,000
from the GRF’s donor-funded General/Health Studies Fund. |
The studies and their principal
investigators are as follows:
Genome
Scanning for Aberrant DNA Methylation in Canine Lymphoma
Principal
Investigator, Laura J. Rush, The Ohio State University;
Lymphoma is
one of the most common cancers in dogs. Scientists already
have documented that genetic alterations contribute to
cancer development, including lymphoma. One such
alteration, DNA promoter methylation, occurs frequently in
human cancers, and investigators believe this change may
also play a key role in canine lymphoma. Investigators will
determine the prevalence of promoter methylation in canine
lymphoma samples to help them uncover key cancer genes that
regulate lymphocyte transformation and the progression of
this disease in dogs. These genes may serve as diagnostic
tumor markers and targets for future molecular therapy in
dogs.
Canine
Lymphoma – the Prognostic Significance of Cytogenic Changes
Principal
Investigator, Dr. Matthew Breen, North Carolina State
University;
Lymphoma
accounts for nearly 25 percent of all cancers in dogs, with
some breeds particularly susceptible. Untreated cases
rarely survive beyond three months after diagnosis. Some
dogs respond to chemotherapy, but overall response and
survival time vary widely, indicating a need to develop more
refined modes of classification. Studies have shown that
the presence of certain chromosome changes in humans with
lymphoma has both diagnostic and prognostic significance. Investigators in this study have identified recurrent
chromosome changes in canine lymphoma and will determine
whether these changes show prognostic significance for dogs
with this cancer. They also may be able to determine
whether these changes are associated with specific breeds at
higher risk for lymphoma.
Candidate
Gene Analysis in Dogs Affected with Hereditary Cataracts
Principal Investigator, Dr. D.J. Sidjanin, Medical College of
Wisconsin.
Cataracts
are one of the top 10 diseases of concern for dogs, and
hereditary cataracts are the most common hereditary eye
disorder in purebreds, affecting nearly 125 breeds. Mutations in at least 26 genes in humans and mice have
already been shown to be associated with the development of
hereditary cataracts, but no such mutations have been
identified in canine genes. The investigators hypothesize
that the mutations that cause cataracts in humans and mice
are also responsible for causing hereditary cataracts in
dogs. In this study they hope to identify the mutations
responsible for causing hereditary cataracts in dogs. Such
findings would allow scientists to develop a blood-based DNA
test that could predict at a young age whether a dog is
normal, a carrier or will be affected with cataracts. Through selective breeding, the mutant gene could be
ultimately eliminated from dog breeds.
Prior to their review and
approval by the GRF Board of Directors, the proposed studies
were reviewed for their science and methodology by the
Golden Retriever Club of America Health and Genetics
Committee.
Since it’s inception in 1948,
the Morris Animal Foundation has sponsored 1200 animal
health studies covering dogs, cats, horses, alpacas, llamas
and even gorillas. Each year, the MAF awards $4 million to
research scientists around the world. In 2006, the Morris
Foundation will be sponsoring 34 dog studies totaling $1.5
million.
POLICY CONCERNING HUMANE TESTING CONDITIONS
In
the wide range of research projects involving the health of animals
and the progress and treatment of disease, certain research
protocols involve the production of disease in an animal under
laboratory conditions, subsequent observation of the progress of the
disease and, sometimes, the reaction of the animal subject to
various treatments. This process may also involve the euthanasia of
the subject so that its body may be studied post mortem.
While the directors of the Golden Retriever Foundation recognize
that this type of live testing is an efficient method of study, we
are also aware that many people consider the use of animals in this
fashion to be morally repugnant. The participation of already
diseased animals, under the protection of their owners, is far
preferable.
Therefore, the Golden Retriever Foundation will reject funding of
any research studies which involve the intentional
production of disease in dogs, including those which involve
killing dogs solely for the purpose
of studying the cadavers. In order to encourage more humane
research, the GRF will endeavor to assist in the recruitment of
suitable, unintentionally afflicted test subjects, and to support
the procurement of viable samples for study from affected dogs which
have died or been euthanized in the normal course of events.
Approved by the Board of Directors June 7, 2006
RACHEL PAGE ELLIOTT EDUCATIONAL FUND SUPPORTS PUBLIC EDUCATION
COMMITTEE
|
 |
The Golden Retriever Foundation Directors have provided
grants from the new “Rachel Page Elliott Educational Fund”
to support the Golden Retriever Club of America's Public
Education Committee activities. Among these are the creation
of a traveling display booth which has appeared multiple
times throughout the year at large cluster dog shows, and
the printing of several informational brochures which are
handed out at the booth. These large show events generally
have an educational component which attract the public
interest. |
Research Contact
Information for Goldens Diagnosed with Cancer
If you
are interested in learning more about on-going cancer studies, or
wish to locate research contact information when a dog is diagnosed
with cancer, please review the convenient summary chart provided by
the GRCA Health & Genetics committee for
Cancer
Contacts.
Donations in support of
the Foundation’s endeavors are critically needed so that the GRF can
continue its mission of funding programs that further the welfare of
the Golden Retriever. All Golden owners are urged to visit these
website sections: How you can help, Directing your donation,
Donations, and
Wills/Bequests when planning their end-of-year
charitable gifts.
Please sign our
Guest Book to receive notices of
updates.
Please see
Golden Retriever Research: A Legacy of Hope.
|